Results 61 to 70 of about 2,054,122 (239)

The Incidence, Severity and Clinical Consequence of Left Pulmonary Artery Stenosis After PDA Device Closure in Premature Infants Less Than 2 Kilograms

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter patent ductus arteriosus (PDA) device closure is an effective treatment option for premature infants with hemodynamically significant PDA. Left pulmonary artery (LPA) stenosis has been reported as a complication, however there is limited data on risk factors, clinical significance, and long‐term outcomes.
Bryan Mosher, Robin Wolschendorf, Preston Boyer, Jimmy C. Lu, Ray Lowery, Sunkyung Yu, Ashley Duimstra, Jeffrey D. Zampi   +7 more
wiley   +1 more source

A Practical Approach to Combined Transcatheter Mitral and Tricuspid Valve Intervention

Frontiers in Cardiovascular Medicine, 2021
Concomitant tricuspid regurgitation (TR) is common in patients with mitral regurgitation (MR). While current guidelines recommend repair of both valves at the time of surgery when feasible, high risk patients are often undertreated, leading to ...
Lucas Burke, Magdi Hassanin, Geraldine Ong, Neil Fam   +3 more
doaj   +1 more source

TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention.

JACC: Cardiovascular Interventions
BACKGROUND Transcatheter tricuspid valve intervention (TTVI) has been increasingly adopted in recent years for the treatment of patients with tricuspid regurgitation (TR).
G. Russo, D. Pedicino, Denise Pires Marafon, M. Adamo, H. Alessandrini, M. Andreas, Daniel Braun, Kim A. Connelly, P. Denti, R. Estévez-Loureiro, N. Fam, Rebecca T. Hahn, C. Harr, J. Hausleiter, D. Himbert, D. Kalbacher, E. Ho, A. Latib, N. Lentini, Edith Lubos, Sebastian Ludwig, P. Lurz, M. Metra, V. Monivas, G. Nickenig, R. Pastorino, Giovanni Pedrazzini, A. Pozzoli, F. Praz, J. Rodés-Cabau, C. Besler, K. Rommel, Joachim Schofer, A. Scotti, K. Piayda, H. Sievert, Gilbert H. L. Tang, H. Thiele, F. Schlotter, Ralph-Stephan von Bardeleben, J. Webb, Stephan Windecker, M. Leon, M. Enriquez-Sarano, Francesco Maisano, Filippo Crea, M. Taramasso   +46 more
semanticscholar   +1 more source

Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Seyed Hossein Aalaei‐Andabili, Diljon S. Chahal, Shahab Tour Savadkohi   +2 more
wiley   +1 more source

Atrioventricular Conduction Disturbances in Patients Undergoing Transcatheter Tricuspid Valve Intervention: A Multidisciplinary Consensus.

JACC: Cardiovascular Interventions
Tricuspid regurgitation (TR) is a highly prevalent valve disease, and cardiac surgery has been used in patients with severe symptomatic TR undergoing surgery for other cardiac lesions or less frequently for isolated TR.
Q. Fischer, K. Ellenbogen, Suneet Mittal, J. Hausleiter, J. Nuche, P. Sorajja, M. Taramasso, V. Thourani, Stephan Windecker, Benoit Labbé, F. Philippon, J. Rodés-Cabau   +11 more
semanticscholar   +1 more source

Imaging Needs in Novel Transcatheter Tricuspid Valve Interventions

JACC: Cardiovascular Imaging, 2018
The advent of novel transcatheter therapies for severe tricuspid regurgitation (TR) has attracted much attention. Novel 3-dimensional imaging techniques have permitted analysis of the tricuspid valve (TV) anatomy from unparalleled views and better understanding of the underlying pathophysiology of TR.
Prihadi, E.A., Delgado, V., Hahn, R.T., Leipsic, J., Min, J.K., Bax, J.J.   +5 more
openaire   +3 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Transcatheter interventions for severe tricuspid regurgitation: a literature review.

Journal of geriatric cardiology : JGC, 2022
The prevalence of tricuspid regurgitation (TR) increases with age, affecting 65%-85% of adults. Primary TR is caused by a congenital or acquired abnormality of the tricuspid valve apparatus (leaflets, chordae, papillary muscles, or annulus). Secondary TR is due to insufficient coaptation from dilation of tricuspid valve annulus due to the right ...
Ponna, Pramod Kumar, Patin, Stephen, Turaga, Naga Sai Shravan, Zoltowska, Dominika M, Devarkonda, Vishal, Botta, Ramya Krishna, Agrawal, Yashwant, Dhar, Gaurav   +7 more
openaire   +2 more sources

Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis.

EuroIntervention, 2021
BACKGROUND Tricuspid regurgitation (TR) has a poor prognosis and limited treatment options and is frequently accompanied by right ventricular (RV) dysfunction. Transcatheter tricuspid valve interventions (TTVI) to reduce TR have been shown to be safe and
F. Schlotter, M. Miura, Karl-Patrik Kresoja, B. Alushi, H. Alessandrini, A. Attinger-Toller, C. Besler, L. Biasco, D. Braun, E. Brochet, K. Connelly, Sabine de Bruijn, P. Denti, R. Estévez-Loureiro, N. Fam, M. Gavazzoni, D. Himbert, E. Ho, J. Juliard, D. Kalbacher, Ryan K Kaple, F. Kreidel, A. Latib, E. Lubos, S. Ludwig, M. Mehr, V. Monivas, T. Nazif, G. Nickenig, G. Pedrazzini, A. Pozzoli, F. Praz, R. Puri, J. Rodés-Cabau, K. Rommel, U. Schäfer, J. Schofer, H. Sievert, G. Tang, H. Thiele, M. Unterhuber, A. Vahanian, R. V. von Bardeleben, Maximilian von Roeder, J. Webb, Marcel Weber, M. Wild, S. Windecker, M. Zuber, J. Hausleiter, F. Maisano, M. Leon, R. Hahn, A. Lauten, M. Taramasso, P. Lurz   +55 more
semanticscholar   +1 more source